This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Awareness of lung cancer risk in people with COPD
February 28, 2019
Pulmonary Rehabilitation – is it worth it?
February 28, 2019
Patient stories from World Aspergillosis Day
February 22, 2019
Air Pollution Worldwide – Check your town
February 15, 2019
Functional medicine: treating depression
February 15, 2019
Beautiful Cure: Harnessing your body’s natural defences
February 15, 2019
Stay Active to Stay Young
February 15, 2019
Helping People Who Are Socially Isolated Using a Robot
February 15, 2019
Caring for our Carers
February 15, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video